Trailing-twelve-month (TTM) revenue is $294.72 Million with a year-over-year growth of (32.40%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $70,809,635 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $74,935,688 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $75,550,484 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $73,424,719 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-17 |
| TTM revenue | $294,720,526 |
Current P/S: $36,251,678 market capitalization ÷ $294,720,526 TTM revenue = 0.12x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:04:19.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $73.42M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:06:21.144Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Major Segments Service Lines Member | $319M | N/A | N/A | N/A |
| Mobile Health Services Segment | N/A | $443M | $423M | $121M |
| Transportation Services Segment | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| PrimaryGeographicalMarketsMember | $319M | N/A | N/A | N/A |
| UNITED KINGDOM | N/A | $52M | $58M | $54M |
| UNITED STATES | N/A | $572M |
$294.72M
$294.72 Million
(32.40%)
vs. $435.98M a year ago (TTM)
+11.63%
5 Year compound annual growth rate
1 Year
(32.40%)
3 Year
(13.26%)
5 Year
+11.63%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $322.20M | ($294.36M) | (47.74%) |
| 2024 | $616.56M | ($7.73M) | (1.24%) |
| 2023 | $624.29M | +$183.77M | +41.72% |
| 2022 | $440.52M | +$121.80M | +38.21% |
| 2021 | $318.72M | +$224.63M | +238.74% |
| 2020 |
TTM Growth
(32.40%)
3-Year CAGR
(13.26%)
5-Year CAGR
+11.63%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:06:21.144Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $193M |
| $201M |
| $268M |
| $94.09M |
| +$45.79M |
| +94.81% |
